Text Size

PET Respiratory Gating to Detect Hepatic Metastasis in Patients With Colon Cancer

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Southwestern Regional Medical Center
ClinicalTrials.gov Identifier:
NCT01401309
First received: January 24, 2011
Last updated: December 10, 2012
Last verified: December 2012
History of Changes
  Purpose

This study is to examine if there is improved sensitivity in detecting hepatic lesions using respiratory gating and if there is an improvement in confidence defining lesions as benign or malignant.


Condition
Colon Cancer

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Effects of Respiratory Gating on FDG/PET Detection of Hepatic Metastasis in Patients With Colon Cancer

Resource links provided by NLM:

MedlinePlus related topics: Cancer
U.S. FDA Resources

Further study details as provided by Southwestern Regional Medical Center:

Primary Outcome Measures:
  • Detecting [ Time Frame: Jan 2011 - Nov 2011 ] [ Designated as safety issue: No ]
    To exam if there is an improved sensitivity in detecting hepatic lesions using respiratory gating and if there is improvement in confidence defining lesions as benign or malignant


Enrollment: 81
Study Start Date: January 2011
Estimated Study Completion Date: December 2013
Primary Completion Date: November 2011 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients with colon cancer

Criteria

Inclusion Criteria:

  • Patients with colon cancer
  • 18 years or older
  • Signed Informed Consent Form
  • Blood Glucose of 200 or less prior to scan

Exclusion Criteria:

  • Patients with known hepatic metastasis
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01401309

Locations
United States, Oklahoma
Cancer Treamtent Centers of America at Southwestern Regional Medical Center, Inc
Tulsa, Oklahoma, United States, 74133
Sponsors and Collaborators
Southwestern Regional Medical Center
  More Information

No publications provided

Responsible Party: Southwestern Regional Medical Center
ClinicalTrials.gov Identifier: NCT01401309     History of Changes
Other Study ID Numbers: SRMC 10-07
Study First Received: January 24, 2011
Last Updated: December 10, 2012
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Colonic Neoplasms
Neoplasm Metastasis
Liver Neoplasms
Colorectal Neoplasms
Intestinal Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
 Neoplasms
Digestive System Diseases
Gastrointestinal Diseases
Colonic Diseases
Intestinal Diseases
Neoplastic Processes
Pathologic Processes
Liver Diseases

ClinicalTrials.gov processed this record on June 18, 2013